Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Sep:50:84-9.
doi: 10.1016/j.cct.2016.07.015. Epub 2016 Jul 25.

Smoking relapse-prevention intervention for cancer patients: Study design and baseline data from the surviving SmokeFree randomized controlled trial

Diana B Díaz  1 , Thomas H Brandon  2 , Steven K Sutton  3 , Lauren R Meltzer  4 , Hannah J Hoehn  5 , Cathy D Meade  6 , Paul B Jacobsen  7 , Judith C McCaffrey  8 , Eric B Haura  9 , Hui-Yi Lin  10 , Vani N Simmons  11
Affiliations
Randomized Controlled Trial

Smoking relapse-prevention intervention for cancer patients: Study design and baseline data from the surviving SmokeFree randomized controlled trial

Diana B Díaz et al. Contemp Clin Trials. 2016 Sep.

Abstract

Continued smoking after a cancer diagnosis contributes to several negative health outcomes. Although many cancer patients attempt to quit smoking, high smoking relapse rates have been observed. This highlights the need for a targeted, evidence-based smoking-relapse prevention intervention. The design, method, and baseline characteristics of a randomized controlled trial assessing the efficacy of a self-help smoking-relapse prevention intervention are presented. Cancer patients who had recently quit smoking were randomized to one of two conditions. The Usual Care (UC) group received the institution's standard of care. The smoking relapse-prevention intervention (SRP) group received standard of care, plus 8 relapse-prevention booklets mailed over a 3month period, and a targeted educational DVD developed specifically for cancer patients. Four hundred and fourteen participants were enrolled and completed a baseline survey. Primary outcomes will be self-reported smoking status at 6 and 12-months after baseline. Biochemical verification of smoking status was completed for a subsample. If found to be efficacious, this low-cost intervention could be easily disseminated with significant potential for reducing the risk of negative cancer outcomes associated with continued smoking.

Keywords: Cancer patients; Randomized controlled trial; Relapse-prevention; Smoking.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intervention and assessment distribution schedule
Figure 2
Figure 2
Participant flow diagram.
See this image and copyright information in PMC

References

    1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328(7455):1519. - PMC - PubMed
    1. Garces YI, Schroeder DR, Nirelli LM, et al. Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysis. Cancer. 2004;101(1):116–124. - PubMed
    1. Westmaas JL, Alcaraz KI, Berg CJ, Stein KD. Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: findings from a nationwide survey nine years after diagnosis. Cancer Epidemiol Biomarkers Prev. 2014;23(9):1783–1792. - PubMed
    1. General USS. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. 2014 http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-....
    1. Simmons VN, Litvin EB, Jacobsen PB, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013;119(7):1420–1427. - PMC - PubMed

Publication types

LinkOut - more resources